Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel in children and adolescents with Bipolar I mania
NCT00090311Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in bipolar I disorder (3 arms), sponsored by AstraZeneca. Primary endpoint: Young Mania Rating Scale at Day 21. Started Jul 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00090311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090311.